- Home
- HUN vs HCM Comparison
HUN vs HCM Comparison
Compare HUN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUN | HCM |
|---|---|---|
| Founded | 1970 | 2000 |
| Country | United States | Hong Kong |
| Employees | 6300 | 1796 |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | HUN | HCM |
|---|---|---|
| Price | $15.10 | $13.47 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 11 | 1 |
| Target Price | $12.09 | ★ $13.75 |
| AVG Volume (30 Days) | ★ 4.9M | 28.2K |
| Earning Date | 04-30-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,683,000,000.00 | N/A |
| Revenue This Year | $3.08 | $20.60 |
| Revenue Next Year | $5.27 | $15.62 |
| P/E Ratio | ★ N/A | $5.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.30 | $12.82 |
| 52 Week High | $15.90 | $19.50 |
Technical Indicators
Market Signals| Indicator | HUN | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 66.14 | 37.58 |
| Support Level | $13.10 | $13.08 |
| Resistance Level | N/A | $15.59 |
| Average True Range (ATR) | 0.76 | 0.42 |
| MACD | 0.10 | -0.14 |
| Stochastic Oscillator | 72.01 | 21.45 |
Price Performance
Historical ComparisonAbout HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.